BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26796597)

  • 21. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
    Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
    J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand.
    Tanière P; Martel-Planche G; Puttawibul P; Casson A; Montesano R; Chanvitan A; Hainaut P
    Int J Cancer; 2000 Oct; 88(2):223-7. PubMed ID: 11004672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?
    Hav M; Libbrecht L; Ferdinande L; Pattyn P; Laurent S; Peeters M; Praet M; Pauwels P
    Virchows Arch; 2011 Feb; 458(2):197-203. PubMed ID: 21113617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P53 and MDM2 isoforms in blood from lung cancer patients.
    Gonzalez-Avila G; Biol JD; Martínez LM; Ramos C; Sommer B
    Exp Lung Res; 2007; 33(5):245-58. PubMed ID: 17620186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM2 copy number increase: a poor prognostic, molecular event in esophageal squamous cell carcinoma.
    Sawada R; Maehara R; Oshikiri T; Nakamura T; Itoh T; Kodama Y; Kakeji Y; Zen Y
    Hum Pathol; 2019 Jul; 89():1-9. PubMed ID: 31004651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDM2 amplification in malignant peripheral nerve sheath tumors correlates with p53 protein expression.
    Wallander ML; Tripp S; Layfield LJ
    Arch Pathol Lab Med; 2012 Jan; 136(1):95-9. PubMed ID: 22208493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus.
    Hanawa M; Suzuki S; Dobashi Y; Yamane T; Kono K; Enomoto N; Ooi A
    Int J Cancer; 2006 Mar; 118(5):1173-80. PubMed ID: 16161046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
    Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
    Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC).
    Dworakowska D; Jassem E; Jassem J; Peters B; Dziadziuszko R; Zylicz M; Jakóbkiewicz-Banecka J; Kobierska-Gulida G; Szymanowska A; Skokowski J; Roessner A; Schneider-Stock R
    Lung Cancer; 2004 Mar; 43(3):285-95. PubMed ID: 15165086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplification and overexpression of Aurora-A in esophageal squamous cell carcinoma.
    Yang SB; Zhou XB; Zhu HX; Quan LP; Bai JF; He J; Gao YN; Cheng SJ; Xu NZ
    Oncol Rep; 2007 May; 17(5):1083-8. PubMed ID: 17390048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P53/MDM2 Co-Expression in Laryngeal Squamous Cell Carcinoma Based on Digital Image Analysis.
    Chrysovergis A; Papanikolaou V; Tsiambas E; Stavraka C; Ragos V; Peschos D; Psyrri A; Mastronikolis N; Kyrodimos E
    Anticancer Res; 2019 Aug; 39(8):4137-4142. PubMed ID: 31366498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TP53 gene deletion in esophageal cancer tissues of patients and its clinical significance.
    Niyaz M; Turghun A; Ping ZH; Zhu Z; Sheyhedin I; Ren C; Awut I
    Mol Med Rep; 2013 Jan; 7(1):122-6. PubMed ID: 23128792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology.
    Qi ZL; Huo X; Xu XJ; Zhang B; Du MG; Yang HW; Zheng LK; Li J; Shen ZY
    Exp Oncol; 2006 Sep; 28(3):235-40. PubMed ID: 17080019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas.
    Zhang W; McElhinny A; Nielsen A; Wang M; Miller M; Singh S; Rueger R; Rubin BP; Wang Z; Tubbs RR; Nagle RB; Roche P; Wu P; Pestic-Dragovich L
    Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):54-61. PubMed ID: 20881839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.
    Waber PG; Chen J; Nisen PD
    Cancer Res; 1993 Dec; 53(24):6028-30. PubMed ID: 8261417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A.
    Elnenaei MO; Gruszka-Westwood AM; A'Hernt R; Matutes E; Sirohi B; Powles R; Catovsky D
    Haematologica; 2003 May; 88(5):529-37. PubMed ID: 12745272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.
    Lim KP; Sharifah H; Lau SH; Teo SH; Cheong SC
    Oncol Rep; 2005 Oct; 14(4):963-8. PubMed ID: 16142358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.